BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10886309)

  • 21. Visuospatial memory deficits at different stages of Parkinson's disease.
    Owen AM; Beksinska M; James M; Leigh PN; Summers BA; Marsden CD; Quinn NP; Sahakian BJ; Robbins TW
    Neuropsychologia; 1993 Jul; 31(7):627-44. PubMed ID: 8371837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hippocampal atrophy is related to impaired memory, but not frontal functions in non-demented Parkinson's disease patients.
    Riekkinen P; Kejonen K; Laakso MP; Soininen H; Partanen K; Riekkinen M
    Neuroreport; 1998 May; 9(7):1507-11. PubMed ID: 9631457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissociating executive mechanisms of task control following frontal lobe damage and Parkinson's disease.
    Rogers RD; Sahakian BJ; Hodges JR; Polkey CE; Kennard C; Robbins TW
    Brain; 1998 May; 121 ( Pt 5)():815-42. PubMed ID: 9619187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perseveration for novel stimuli in Parkinson's disease: an evaluation based on event-related potentials topography.
    Hozumi A; Hirata K; Tanaka H; Yamazaki K
    Mov Disord; 2000 Sep; 15(5):835-42. PubMed ID: 11009188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry.
    Zgaljardic DJ; Borod JC; Foldi NS; Mattis P
    Cogn Behav Neurol; 2003 Dec; 16(4):193-210. PubMed ID: 14665819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Frontal cortical dysfunction in Parkinson's disease (PD): Comparison of memory-based smooth-pursuit and anti-saccade tasks, and neuropsychological and motor symptom evaluations].
    Ito N; Takei H; Chiba S; Fukushima K
    Rinsho Shinkeigaku; 2016 Nov; 56(11):747-753. PubMed ID: 27773904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Deficits in memory retrieval: an argument in favor of frontal subcortical dysfunction in depression].
    Fossati P; Deweer B; Raoux N; Allilaire JF
    Encephale; 1995; 21(4):295-305. PubMed ID: 7588169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of cognitive reserve with motor and cognitive functions for different stages of Parkinson's disease.
    Guzzetti S; Mancini F; Caporali A; Manfredi L; Daini R
    Exp Gerontol; 2019 Jan; 115():79-87. PubMed ID: 30502539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential optimal dopamine levels for set-shifting and working memory in Parkinson's disease.
    Fallon SJ; Smulders K; Esselink RA; van de Warrenburg BP; Bloem BR; Cools R
    Neuropsychologia; 2015 Oct; 77():42-51. PubMed ID: 26239947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implicit and explicit memory in patients with Parkinson's disease with and without dementia.
    Appollonio I; Grafman J; Clark K; Nichelli P; Zeffiro T; Hallett M
    Arch Neurol; 1994 Apr; 51(4):359-67. PubMed ID: 8155013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of cognitive set flexibility in Parkinson's disease.
    Cools R; Barker RA; Sahakian BJ; Robbins TW
    Brain; 2001 Dec; 124(Pt 12):2503-12. PubMed ID: 11701603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Object alternation and orbitofrontal system dysfunction in Alzheimer's and Parkinson's disease.
    Freedman M
    Brain Cogn; 1990 Nov; 14(2):134-43. PubMed ID: 2285509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Event based and time based prospective memory in Parkinson's disease.
    Katai S; Maruyama T; Hashimoto T; Ikeda S
    J Neurol Neurosurg Psychiatry; 2003 Jun; 74(6):704-9. PubMed ID: 12754335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The alpha2 agonist, clonidine, improves spatial working performance in Parkinson's disease.
    Riekkinen M; Jäkälä P; Kejonen K; Riekkinen P
    Neuroscience; 1999; 92(3):983-9. PubMed ID: 10426538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revisiting the effects of Parkinson's disease and frontal lobe lesions on task switching: the role of rule reconfiguration.
    Kehagia AA; Barker RA; Robbins TW
    J Neuropsychol; 2014 Mar; 8(1):53-74. PubMed ID: 23279799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visuo-cognitive dysfunctions in Parkinson's disease.
    Antal A; Bandini F; Kéri S; Bodis-Wollner I
    Clin Neurosci; 1998; 5(2):147-52. PubMed ID: 10785841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow.
    Taylor AE; Saint-Cyr JA; Lang AE
    Brain; 1986 Oct; 109 ( Pt 5)():845-83. PubMed ID: 3779372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopaminergic effects on cognitive performance in patients with Parkinson's disease.
    Lange KW; Paul GM; Naumann M; Gsell W
    J Neural Transm Suppl; 1995; 46():423-32. PubMed ID: 8821078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive deficits in the early stages of Parkinson's disease.
    Lees AJ; Smith E
    Brain; 1983 Jun; 106 (Pt 2)():257-70. PubMed ID: 6850270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.